SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-21-238543
Filing Date
2021-08-06
Accepted
2021-08-06 07:48:01
Documents
107
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d151296d6k.htm 6-K 25430
2 EX-5.1 d151296dex51.htm EX-5.1 22333
3 EX-99.1 d151296dex991.htm EX-99.1 683185
10 GRAPHIC g151296g71m87.jpg GRAPHIC 2916
  Complete submission text file 0001193125-21-238543.txt   8527477

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT asln-20210630.xml EX-101.INS 2527312
5 XBRL TAXONOMY EXTENSION SCHEMA asln-20210630.xsd EX-101.SCH 90729
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE asln-20210630_cal.xml EX-101.CAL 55615
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE asln-20210630_def.xml EX-101.DEF 328886
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE asln-20210630_lab.xml EX-101.LAB 532491
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE asln-20210630_pre.xml EX-101.PRE 475160
Mailing Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920
Business Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920 65 6222 4235
ASLAN Pharmaceuticals Ltd (Filer) CIK: 0001722926 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38475 | Film No.: 211150592
SIC: 2834 Pharmaceutical Preparations